John K MacDonald Selected Research

Remission Induction

12/2020	Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
11/2019	Adalimumab for induction of remission in Crohn's disease.
1/2018	Low dose naltrexone for induction of remission in Crohn's disease.
1/2018	Natalizumab for induction of remission in Crohn's disease.
11/2016	Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease.
10/2016	Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
7/2016	Aminosalicylates for induction of remission or response in Crohn's disease.
4/2016	Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
12/2015	Etrolizumab for induction of remission in ulcerative colitis.
10/2015	Oral budesonide for induction of remission in ulcerative colitis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John K MacDonald Research Topics

Disease

25	Crohn Disease (Crohn's Disease) 05/2020 - 07/2012
21	Ulcerative Colitis 12/2020 - 09/2011
7	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2022 - 09/2011
5	Nausea 02/2019 - 08/2014
4	Abscess 01/2022 - 08/2014
4	Colitis 01/2022 - 09/2015
4	Exanthema (Rash) 11/2017 - 08/2014
3	Fistula 02/2019 - 04/2013
3	Headache (Headaches) 02/2019 - 01/2017
3	Vomiting 02/2019 - 01/2017
3	Abdominal Pain (Pain, Abdominal) 11/2017 - 07/2014
2	Enterocolitis 01/2022 - 01/2022
2	Necrosis 05/2020 - 02/2019
2	Pancreatitis 09/2019 - 05/2016
2	Inflammation (Inflammations) 11/2018 - 07/2017
2	Marijuana Abuse (Cannabis Abuse) 11/2018 - 11/2018
2	Weight Gain 11/2018 - 11/2017
2	Collagenous Colitis 11/2017 - 01/2009
2	Neck Pain (Cervicalgia) 11/2017 - 01/2017
2	Lymphocytic Colitis 01/2017 - 01/2009
2	Venous Thromboembolism 01/2017 - 02/2016
2	Infections 11/2016 - 05/2015
2	Injection Site Reaction 11/2016 - 05/2015
2	Hypoalbuminemia 08/2015 - 08/2014
2	Alopecia (Baldness) 08/2015 - 08/2014
2	Pneumonia (Pneumonitis) 08/2015 - 08/2014
2	Dyspepsia (Indigestion) 08/2015 - 08/2014
2	Migraine Disorders (Migraine) 08/2015 - 08/2014
1	Lymphocytosis 01/2022
1	Neoplasms (Cancer) 01/2022
1	Lymphedema (Milroy Disease) 01/2021
1	Leukopenia 09/2019
1	Pain (Aches) 04/2019
1	Fatigue 02/2019
1	Respiratory Tract Infections (Respiratory Tract Infection) 02/2019
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Dizziness (Lightheadedness) 11/2018
1	Wounds and Injuries (Trauma) 09/2017
1	Colorectal Neoplasms (Colorectal Cancer) 05/2017
1	Hyperhidrosis 01/2017
1	Hemorrhage 01/2017
1	Sleepiness 01/2017

Drug/Important Bio-Agent (IBA)

13	Mesalamine (Mesalazine)FDA LinkGeneric 12/2020 - 01/2009
7	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 08/2014
5	Budesonide (Pulmicort)FDA LinkGeneric 01/2022 - 01/2009
5	Azathioprine (Imuran)FDA LinkGeneric 10/2016 - 04/2013
5	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 10/2016 - 04/2013
4	CytokinesIBA 12/2019 - 05/2015
4	Monoclonal AntibodiesIBA 12/2019 - 05/2015
4	C-Reactive ProteinIBA 11/2018 - 06/2015
4	Leukocyte L1 Antigen Complex (Calgranulin)IBA 11/2018 - 06/2015
4	Methotrexate (Mexate)FDA LinkGeneric 08/2015 - 08/2014
3	Pharmaceutical PreparationsIBA 10/2022 - 08/2015
3	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022 - 08/2015
3	vedolizumabIBA 01/2022 - 08/2014
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2022
3	CannabinoidsIBA 01/2020 - 11/2018
3	AntibodiesIBA 12/2019 - 05/2015
3	briakinumabIBA 12/2019 - 05/2015
3	Interleukin-23 (Interleukin 23)IBA 12/2019 - 05/2015
3	Ustekinumab (CNTO 1275)FDA Link 12/2019 - 05/2015
3	Interleukin-12 (IL 12)IBA 12/2019 - 05/2015
3	Prednisolone (Predate)FDA LinkGeneric 11/2017 - 01/2009
3	SteroidsIBA 10/2016 - 04/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2022 - 11/2019
2	Infliximab (Remicade)FDA Link 01/2022 - 10/2015
2	PlasticsIBA 01/2021 - 02/2016
2	Adalimumab (Humira)FDA Link 05/2020 - 11/2019
2	LactoferrinIBA 07/2017 - 06/2015
2	Cholestyramine Resin (Questran)FDA LinkGeneric 01/2017 - 01/2009
2	bismuth subsalicylate (Pepto-bismol)FDA LinkGeneric 01/2017 - 01/2009
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 09/2016 - 07/2016
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 08/2015 - 08/2014
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 08/2015 - 09/2011
2	Heparin (Liquaemin)FDA LinkGeneric 08/2015 - 09/2011
1	CollagenIBA 01/2022
1	IpilimumabIBA 01/2022
1	Immunoglobulin G (IgG)IBA 11/2019
1	purineIBA 09/2019
1	Analgesics (Analgesic Drugs)IBA 04/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2019
1	EndocannabinoidsIBA 11/2018
1	CannabidiolIBA 11/2018
1	Naltrexone (ReVia)FDA LinkGeneric 01/2018
1	Natalizumab (Tysabri)FDA Link 01/2018
1	Opioid Analgesics (Opioids)IBA 01/2018

Therapy/Procedure

27	Therapeutics 01/2021 - 04/2013
18	Remission Induction 12/2020 - 09/2011
2	Chemoprevention 01/2017 - 02/2016
1	Immunotherapy 01/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Fecal Microbiota Transplantation 01/2022
1	Transplantation 01/2021
1	Lymph Node Excision (Lymph Node Dissection) 01/2021
1	Lipectomy (Liposuction) 01/2021
1	Biological Therapy 05/2020
1	Enteral Nutrition (Feeding, Tube) 11/2018
1	Length of Stay 09/2017
1	Colectomy 05/2017
1	Precision Medicine 01/2017